Abstract 1219: In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables ATAD3A gene depletion to enhance RAS-targeted therapy

Authors: Fanghui Chen, Liwei Lang, Yamin Li, Wei Zheng, Yong Teng

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-1219

Source: Full article

---

Abstract

Abstract